Epidemiological characteristics and influencing factors of acute leukemia in children and adolescents and adults: a large population-based study

References

• Alsalem MA, Zaidan AA, Zaidan BB, et al. A review of the automated detection and classification of acute leukaemia: coherent taxonomy, datasets, validation and performance measurements, motivation, open challenges and recommendations. Comput Methods Programs Biomed. 2018;158:93–112. doi:10.1016/j.cmpb.2018.02.005
   PubMed Web of Science ®Google Scholar
• Seth R, Singh A. Leukemias in children. Indian J Pediatr. 2015;82(9):817–824. doi:10.1007/s12098-015-1695-5
   PubMed Web of Science ®Google Scholar
• Barr RD, Gomez-Almaguer D, Jaime-Perez JC, et al. Importance of nutrition in the treatment of leukemia in children and adolescents. Arch Med Res. 2016;47(8):585–592. doi:10.1016/j.arcmed.2016.11.013
   PubMed Web of Science ®Google Scholar
• Stat bite: estimated new leukemia cases in 2008. J Natl Cancer Inst. 2008;100(8):531. doi:10.1093/jnci/djn111
   PubMedGoogle Scholar
• Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350(15):1535–1548. doi:10.1056/NEJMra023001
   PubMed Web of Science ®Google Scholar
• Hunault M, Harousseau JL, Delain M, et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004;104(10):3028–3037. doi:10.1182/blood-2003-10-3560
   PubMed Web of Science ®Google Scholar
• Yang JJ, Cheng C, Devidas M, et al. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood. 2012;120(20):4197–4204. doi:10.1182/blood-2012-07-440107
   PubMed Web of Science ®Google Scholar
• Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood. 2015;125(26):3977–3987. doi:10.1182/blood-2015-02-580043
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Hermiston ML. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities. Br J Haematol. 2019;185(6):1158–1170. doi:10.1111/bjh.15793
   PubMed Web of Science ®Google Scholar
• De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441. doi:10.1038/bcj.2016.50
   PubMed Web of Science ®Google Scholar
• Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.
   PubMedGoogle Scholar
• Nasir SS, Giri S, Nunnery S, et al. Outcome of adolescents and young adults compared with pediatric patients with acute myeloid and promyelocytic leukemia. Clin Lymphoma Myeloma Leuk. 2017;17(2):126–132.e1. doi:10.1016/j.clml.2016.09.011
   PubMed Web of Science ®Google Scholar
• Elgarten CW, Aplenc R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr. 2020;32(1):57–66. doi:10.1097/MOP.0000000000000855
   PubMed Web of Science ®Google Scholar
• Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16):3187–3205. doi:10.1182/blood-2012-03-362608
   PubMed Web of Science ®Google Scholar
• Zhong J, Yu X, Zhang X. Comparison of overall survival between de novo and secondary acute lymphoblastic leukemia patients of different ages. Clin Lymphoma Myeloma Leuk. 2020;20(9):e622–e627. doi:10.1016/j.clml.2020.04.013
   PubMed Web of Science ®Google Scholar
• Kamath GR, Tremblay D, Coltoff A, et al. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia. Carcinogenesis. 2019;40(5):651–660. doi:10.1093/carcin/bgz014
   PubMed Web of Science ®Google Scholar
• Cronin KA, Ries LA, Edwards BK. The surveillance, epidemiology, and end results (SEER) program of the National Cancer Institute. Cancer. 2014;120(Suppl 23):3755–3757. doi:10.1002/cncr.29049
   PubMed Web of Science ®Google Scholar
• Duggan MA, Anderson WF, Altekruse S, et al. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94–e102. doi:10.1097/PAS.0000000000000749
   PubMed Web of Science ®Google Scholar
• Song X, Peng Y, Wang X, et al. Incidence, survival, and risk factors for adults with acute myeloid leukemia not otherwise specified and acute myeloid leukemia with recurrent genetic abnormalities: analysis of the surveillance, epidemiology, and end results (SEER) database, 2001–2013. Acta Haematol. 2018;139(2):115–127. doi:10.1159/000486228
   PubMed Web of Science ®Google Scholar
• Qasrawi A, Gomes V, Chacko CA, et al. Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database. Leuk Res. 2020;89:106301. doi:10.1016/j.leukres.2020.106301
   PubMed Web of Science ®Google Scholar
• Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34–43. doi:10.1182/blood-2011-04-347872
   PubMed Web of Science ®Google Scholar
• Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol. 2009;36(3):213–226. doi:10.1053/j.seminoncol.2009.03.007
   PubMed Web of Science ®Google Scholar
• Ganzel C, Rowe JM. Prognostic factors in adult acute leukemia. Hematol Oncol Clin North Am. 2011;25(6):1163–1187. doi:10.1016/j.hoc.2011.09.017
   PubMed Web of Science ®Google Scholar
• Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int Off J Jpn Pediatr Soc. 2018;60(1):4–12. doi:10.1111/ped.13457
   Google Scholar
• Fielding AK, Richards SM, Chopra R, et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2007;109(3):944–950. doi:10.1182/blood-2006-05-018192
   PubMed Web of Science ®Google Scholar
• Juliusson G, Hough R. Leukemia. Prog Tumor Res. 2016;43:87–100. doi:10.1159/000447076
   PubMed Web of Science ®Google Scholar
• Kristinsson SY, Derolf AR, Edgren G, et al. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(12):2073–2080. doi:10.1200/JCO.2008.18.2006
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Peterson B, Dodge RK, et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood. 2004;103(11):4036–4042. doi:10.1182/blood-2003-09-3118
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Y, Ma S. Racial differences in four leukemia subtypes: comprehensive descriptive epidemiology. Sci Rep. 2018;8(1):548. doi:10.1038/s41598-017-19081-4
   PubMedGoogle Scholar
• Abraham IE, Patel AA, Wang H, et al. Impact of race on outcomes in intermediate-risk acute myeloid leukemia. Cancer Causes Control. 2021;32(7):705–712. doi:10.1007/s10552-021-01422-4
   PubMed Web of Science ®Google Scholar
• Eche IJ, Aronowitz T. A literature review of racial disparities in overall survival of black children with acute lymphoblastic leukemia compared with white children with acute lymphoblastic leukemia. J Pediatr Oncol Nurs Off J Assoc Pediatr Oncol Nurses. 2020;37(3):180–194. doi:10.1177/1043454220907547
   PubMed Web of Science ®Google Scholar
• Jamy OH, Godby R, Dhir A, et al. Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States. Cancer. 2021;127(16):2966–2973. doi:10.1002/cncr.33593
   PubMed Web of Science ®Google Scholar
• Pulte D, Castro FA, Brenner H, et al. Outcome disparities by insurance type for patients with acute myeloblastic leukemia. Leuk Res. 2017;56:75–81. doi:10.1016/j.leukres.2017.02.001
   PubMed Web of Science ®Google Scholar
• Joshi U, Khanal S, Bhetuwal U, et al. Impact of insurance on overall survival in acute lymphoblastic leukemia: a SEER database study. Clin Lymphoma Myeloma Leuk. 2022;22(7):e477–e484. doi:10.1016/j.clml.2022.01.001
   PubMed Web of Science ®Google Scholar